What's Trending
Your source for perspectives, case studies and resources on the trends shaping oncology and cardiology benefit management
-
Read ArticlePatient Impact Story: Clinical Review Catches Potential Medical Error
Red flags cause clinical reviewers to question a radiation oncologist’s diagnosis.
-
Read External ArticleAccelerated Drug Approvals Present a Mounting Challenge to Oncologists
Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.
-
Watch VideoA Plea for Better Endings
Confronting the heart-wrenching, avoidable circumstances that happen in hospitals and homes every day.
-
Watch VideoPanel Discussion: Oncology Care Reimagined
Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.
- Let's Go
-
Listen to podcastEpisode 7: Underuse In Cardiology Is Under-Appreciated. How Do We Change That?
Learn why underuse is a major problem and how we might tackle it
-
Read External ArticleLocation, Location, Location. That Also Applies to Cancer Treatment.
Home-based chemotherapy infusions may offer convenience but also raise a host of questions.
-
Read ArticleShouldering the Burden and Financial Toxicity of Part D Cancer Drugs
Discussing drug costs should be a core tenet of shared decision-making.
-
Read Press ReleaseNew Century Health Parent Company Elects Dr. Tunde Sotunde To Board Of Directors
Sotunde is president and CEO of Blue Cross and Blue Shield of North Carolina.
-
Read Press ReleaseNew Century Health to Support Health New England With Comprehensive Advance Care Planning Services
Partnership will empower members with serious illness to articulate and advocate for the care they want.
-
Read External ArticleSpecialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says
Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.
-
Listen to podcastEpisode 6: Why Don't More Cardiology Patients Get Optimal Medication Therapy?
GDMT, or guideline-directed medical therapy, means taking the right medication at the optimal doses to treat cardiovascular problems. Yet these medications are chronically underused.
-
Listen to PodcastEpisode 5: Will COVID-19 Change What Is Considered Appropriate Use in Cardiology?
Every day, cardiologists make decisions about what is the most appropriate test, therapy, or procedure for their patients. But then COVID-19 came along. Have the rules of the game changed?
-
Read External ArticleThe Mainstreaming of Targeted Lung Cancer Treatment
Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.
-
Read ArticleHealth Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals
Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.
-
Read ArticleSpecialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies
Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.
-
Read ArticleEvolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions
The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.
-
Read ArticleHitting the Brakes on Fast-Tracked Drugs
The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.
-
Read ArticleTop Takeaways from the 2021 ASCO Annual Meeting
Our chief medical officer highlights noteworthy research and results from clinical oncology's premier event.
-
Read ArticleNew Century Health Supports Neighborhood Health Plan of Rhode Island with Comprehensive Oncology Management Services
New Century Health, a national leader in specialty care management, is proud to provide comprehensive oncology specialty management services to Neighborhood Health Plan of Rhode Island.
-
Watch VideoCMO Dr. Andrew Hertler Reacts to the FDA's Recent ODAC Meeting
New Century Health CMO, Dr. Andrew Hertler, shares his thoughts on the recent FDA meetings to review the merits of approved cancer drugs.
-
Read External ArticleA now-or-never moment for telehealth?
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
-
Loading More...
